CVS Health Corp (NYSE: CVS) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.31 versus $1.59 for the same period a year ago — a decline of -18%. Relative to the consensus estimate of $0.94, this was a premium of $0.37. E.P.S. were $3.67 for the latest four quarters through December 31 versus $6.49 for the same period a year ago — a decline of -43%.
Recent Price Action
CVS Health Corp (NYSE: CVS) stock enjoyed a major increase of 14.9% on 2/12/25. The shares closed at $63.22. Moreover, exceptionally high trading volume at 255% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 12.2% during the last week.
Current PriceTarget Research Rating
CVS Health has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. CVS Health has a very high Appreciation Score of 94 but a poor Power Rating of 23, triggering the High Neutral Value Trend Rating.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment